$ELDN
Eledon Pharmaceuticals, Inc.

2017 Q4 Form 10-K Financial Statement

#000156459018007314 Filed on April 02, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.610M $11.10M $2.720M
YoY Change -40.81% -15.27% -18.56%
% of Gross Profit
Research & Development $490.0K $2.022M $1.040M
YoY Change -52.88% -91.92% -86.55%
% of Gross Profit
Depreciation & Amortization $0.00 $20.00K $20.00K
YoY Change -100.0% -88.3% -66.67%
% of Gross Profit
Operating Expenses $2.110M $2.022M $3.760M
YoY Change -43.88% -94.7% -66.03%
Operating Profit -$13.12M -$3.760M
YoY Change 155.87% -66.04%
Interest Expense $20.00K
YoY Change -66.67%
% of Operating Profit
Other Income/Expense, Net -$10.00K $5.000K
YoY Change -100.95%
Pretax Income -$2.110M -$12.47M -$3.740M
YoY Change -43.58% 334.49% -66.06%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.110M -$13.12M -$3.737M
YoY Change -43.54% 131.94% -66.08%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$5.275M -$50.46M -$26.71M
COMMON SHARES
Basic Shares Outstanding 22.64M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.20M $17.20M $27.40M
YoY Change -37.23% -37.23% -57.19%
Cash & Equivalents $17.23M $17.20M $1.103M
Short-Term Investments $4.200M
Other Short-Term Assets $18.00K $1.800M $33.00K
YoY Change -45.45% -18.18% -98.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $19.00M $19.00M $1.150M
YoY Change 1552.17% -35.59% -98.29%
LONG-TERM ASSETS
Property, Plant & Equipment $25.00K $0.00 $31.00K
YoY Change -19.35% -100.0% -93.66%
Goodwill $1.867M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $15.00K
YoY Change -100.0% -100.0% -66.67%
Total Long-Term Assets $1.892M $1.900M $46.00K
YoY Change 4013.04% 533.33% -94.28%
TOTAL ASSETS
Total Short-Term Assets $19.00M $19.00M $1.150M
Total Long-Term Assets $1.892M $1.900M $46.00K
Total Assets $20.89M $20.90M $1.196M
YoY Change 1646.82% -29.87% -98.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $418.0K $400.0K $338.0K
YoY Change 23.67% 0.0% -72.02%
Accrued Expenses $1.000M $1.000M $113.0K
YoY Change 784.96% -58.33% -97.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.400M $1.400M $3.898M
YoY Change -64.08% -50.0% -36.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $84.00K
YoY Change -100.0% -100.0% -4.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.400M $1.400M $3.898M
Total Long-Term Liabilities $0.00 $0.00 $84.00K
Total Liabilities $1.440M $1.400M $3.898M
YoY Change -63.06% -51.72% -37.63%
SHAREHOLDERS EQUITY
Retained Earnings -$27.51M -$14.39M
YoY Change 91.15% -89.05%
Common Stock $46.96M $11.39M
YoY Change 312.42% -94.11%
Preferred Stock $0.00 $291.0K
YoY Change -100.0%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.45M $19.50M -$2.702M
YoY Change
Total Liabilities & Shareholders Equity $20.89M $20.90M $1.196M
YoY Change 1646.82% -29.87% -98.24%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$2.110M -$13.12M -$3.737M
YoY Change -43.54% 131.94% -66.08%
Depreciation, Depletion And Amortization $0.00 $20.00K $20.00K
YoY Change -100.0% -88.3% -66.67%
Cash From Operating Activities -$2.610M -$14.94M -$7.310M
YoY Change -64.3% -59.09% -17.68%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $23.26M $11.90M
YoY Change -100.0% -34.85% -12000.0%
Cash From Investing Activities $0.00 $23.26M $11.90M
YoY Change -100.0% -34.82% -3818.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.750M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 750.0K 7.869M 0.000
YoY Change 19572.5% -100.0%
NET CHANGE
Cash From Operating Activities -2.610M -14.94M -7.310M
Cash From Investing Activities 0.000 23.26M 11.90M
Cash From Financing Activities 750.0K 7.869M 0.000
Net Change In Cash -1.860M 16.19M 4.590M
YoY Change -140.52% -912.55% -150.11%
FREE CASH FLOW
Cash From Operating Activities -$2.610M -$14.94M -$7.310M
Capital Expenditures $0.00
Free Cash Flow -$7.310M
YoY Change -15.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3447000
CY2016Q4 us-gaap Liabilities
Liabilities
3898000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 dei Entity Public Float
EntityPublicFloat
40621417
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17233000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1103000
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
70000
CY2016Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
14000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1697000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
19000000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
1150000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31000
CY2017Q4 us-gaap Goodwill
Goodwill
1867000
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000
CY2016Q4 us-gaap Assets
Assets
1196000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
338000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1992000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3109000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17303000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46951000
CY2016Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
291000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-527000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-13116000
CY2017 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-10778000
CY2016 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-941000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-13121000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-5128000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-5655000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.30
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.46
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4677610
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
382747
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
2782000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
171000
CY2017 nvus Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3119000
CY2017 nvus Conversion Of Convertible Notes And Accrued Interest Value
ConversionOfConvertibleNotesAndAccruedInterestValue
3447000
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
23375000
CY2017 nvus Stock Issued During Period Share Issued For Cash Value
StockIssuedDuringPeriodShareIssuedForCashValue
4000000
CY2017 nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
750000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
579000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
579000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
171000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-49000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-517000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
517000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-65000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1958000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-65000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14941000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4923000
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
23250000
CY2017 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
8000
CY2016 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
10000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
23258000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4750000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3119000
CY2016 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2930000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7869000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2930000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16186000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1117000
CY2017 nvus Conversion Of Promissory Notes And Interest To Common Stock
ConversionOfPromissoryNotesAndInterestToCommonStock
3447000
CY2017 nvus Conversion Of Contingently Issuable Shares To Common Stock
ConversionOfContingentlyIssuableSharesToCommonStock
291000
CY2017 us-gaap Stock Issued1
StockIssued1
23375000
CY2017 nvus Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
27000
CY2017 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
3072000
CY2017 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
2947000
CY2017 nvus Fair Value Of Assets Acquired And Liabilities Assumed In Merger
FairValueOfAssetsAcquiredAndLiabilitiesAssumedInMerger
125000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.86%;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s financial statements relate to the valuation of the convertible debt instrument, stock-based compensation, accruals for liabilities, carrying value of goodwill, and other matters that affect the consolidated financial statements and related disclosures. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements. </p></div>
CY2017Q4 nvus Working Capital
WorkingCapital
17600000
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
840115
CY2017 nvus Cash Cash Equivalents And Restricted Cash Maturity Period
CashCashEquivalentsAndRestrictedCashMaturityPeriod
three months or less
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
531000
CY2017 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2017 nvus Interest Accumulated On Preferred Shares And Contingently Issuable For Little Or No Cash
InterestAccumulatedOnPreferredSharesAndContingentlyIssuableForLittleOrNoCash
328000
CY2016 nvus Interest Accumulated On Preferred Shares And Contingently Issuable For Little Or No Cash
InterestAccumulatedOnPreferredSharesAndContingentlyIssuableForLittleOrNoCash
917000
CY2017 nvus Net Income Loss Attributable To Shareholders Of Preferred Shares And Contingently Issuable For Little Or No Cash
NetIncomeLossAttributableToShareholdersOfPreferredSharesAndContingentlyIssuableForLittleOrNoCash
2666000
CY2016 nvus Net Income Loss Attributable To Shareholders Of Preferred Shares And Contingently Issuable For Little Or No Cash
NetIncomeLossAttributableToShareholdersOfPreferredSharesAndContingentlyIssuableForLittleOrNoCash
5631000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400735
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8153389
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.
CY2017Q4 nvus Income Tax Examination Likelihood Of Favorable Settlement
IncomeTaxExaminationLikelihoodOfFavorableSettlement
0.50
CY2017 nvus Business Acquisition Pro Forma Research And Development Expense
BusinessAcquisitionProFormaResearchAndDevelopmentExpense
2481000
CY2016 nvus Business Acquisition Pro Forma Research And Development Expense
BusinessAcquisitionProFormaResearchAndDevelopmentExpense
28215000
CY2017 nvus Business Acquisition Pro Forma General And Administrative Expense
BusinessAcquisitionProFormaGeneralAndAdministrativeExpense
9356000
CY2016 nvus Business Acquisition Pro Forma General And Administrative Expense
BusinessAcquisitionProFormaGeneralAndAdministrativeExpense
14361000
CY2017 nvus Business Acquisition Pro Forma Operating Expenses
BusinessAcquisitionProFormaOperatingExpenses
11837000
CY2016 nvus Business Acquisition Pro Forma Operating Expenses
BusinessAcquisitionProFormaOperatingExpenses
42576000
CY2017 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-11837000
CY2016 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-42576000
CY2017 nvus Business Acquisition Pro Forma Other Nonoperating Income Expense
BusinessAcquisitionProFormaOtherNonoperatingIncomeExpense
45000
CY2016 nvus Business Acquisition Pro Forma Other Nonoperating Income Expense
BusinessAcquisitionProFormaOtherNonoperatingIncomeExpense
154000
CY2017 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-11792000
CY2016 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-42422000
CY2017 nvus Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic And Diluted
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasicAndDiluted
-2.52
CY2016 nvus Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic And Diluted
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasicAndDiluted
-5.89
CY2017 nvus Business Acquisitions Pro Forma Weighted Average Shares Outstanding Basic And Diluted
BusinessAcquisitionsProFormaWeightedAverageSharesOutstandingBasicAndDiluted
4677610
CY2016 nvus Business Acquisitions Pro Forma Weighted Average Shares Outstanding Basic And Diluted
BusinessAcquisitionsProFormaWeightedAverageSharesOutstandingBasicAndDiluted
7208003
CY2016Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
531000
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3447000
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1518000
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
161000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
33000
CY2017Q4 nvus Accrued Clinical Current
AccruedClinicalCurrent
85000
CY2016Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
51000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
158000
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
111000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
50000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12000
CY2017 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1867000
CY2017Q4 us-gaap Goodwill Gross
GoodwillGross
1867000
CY2016Q3 nvus Percentage Of Discount On Common Stock
PercentageOfDiscountOnCommonStock
0.15
CY2016Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3400000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
188000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
112000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
112000
CY2017 nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2016 nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2017Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2017Q4 nvus Contingent Liability
ContingentLiability
0
CY2017 nvus Number Of Stock Compensation Plans
NumberOfStockCompensationPlans
2
CY2017 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.111111111
CY2017 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one for nine
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
63627
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13054
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2120
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8074
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6710
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59777
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
595800
CY2017 nvus Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Reverse Merger
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseMerger
37000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10377
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
682200
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
682200
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
143657
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.70
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.75
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.06
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
19.01
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
19.75
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.45
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.54
CY2017 nvus Share Based Compensation Arrangements By Share Based Payment Award Options Assumed Reverse Merger Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedReverseMergerWeightedAverageExercisePrice
5.84
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.78
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.65
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.65
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.68
CY2017Q4 nvus Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M12D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y8M12D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2100
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4300
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8600
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8600
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8600
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2300000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.93
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.78
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.86
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0095
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.01
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12470000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2870000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-646000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2785000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13116000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5655000
CY2016 nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.35
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q4 nvus Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
1900000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4460000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1923000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
59000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
328000
CY2017 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2000
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
58000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1859000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
135000
CY2017 nvus Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
693000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
43000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
404000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1673000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1249000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4516000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2928000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
95000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
58000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
221000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
360000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
48000
CY2017Q4 nvus Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
139000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5019000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3346000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5019000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3346000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
75000
CY2016Q4 nvus Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
8094073
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
106000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1700000
CY2017 nvus Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards
PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards
P3Y
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8094073
CY2016Q4 nvus Underlying Shares Issued
UnderlyingSharesIssued
0
CY2017Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
0

Files In Submission

Name View Source Status
0001564590-18-007314-index-headers.html Edgar Link pending
0001564590-18-007314-index.html Edgar Link pending
0001564590-18-007314.txt Edgar Link pending
0001564590-18-007314-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018033101370150433501.jpg Edgar Link pending
g2018033101370152033502.jpg Edgar Link pending
nvus-10k_20171231.htm Edgar Link pending
nvus-20171231.xml Edgar Link completed
nvus-20171231.xsd Edgar Link pending
nvus-20171231_cal.xml Edgar Link unprocessable
nvus-20171231_def.xml Edgar Link unprocessable
nvus-20171231_lab.xml Edgar Link unprocessable
nvus-20171231_pre.xml Edgar Link unprocessable
nvus-ex1010_428.htm Edgar Link pending
nvus-ex1011_429.htm Edgar Link pending
nvus-ex1012_430.htm Edgar Link pending
nvus-ex211_12.htm Edgar Link pending
nvus-ex231_149.htm Edgar Link pending
nvus-ex232_148.htm Edgar Link pending
nvus-ex311_11.htm Edgar Link pending
nvus-ex312_10.htm Edgar Link pending
nvus-ex321_8.htm Edgar Link pending
nvus-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending